CD33 and neoplasm: Those cells are now known as granulocytic MDSC, or PMN-MDSC (CD11b+HLA-DR−/low CD33+ CD15+ CD14−), one of several subpopulations of MDSC responsible for profound suppression of anti-tumor immunity and failure of anti-tumor immunotherapy.